首页 > 最新文献

Janac-Journal of the Association of Nurses in Aids Care最新文献

英文 中文
Impact of Food Insecurity and Undernutrition on Frailty and Physical Functioning in Aging People With HIV in the United States. 食品不安全和营养不良对美国老年艾滋病病毒感染者虚弱程度和身体机能的影响。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-05-01 Epub Date: 2023-02-08 DOI: 10.1097/JNC.0000000000000395
Christine Horvat Davey, Brianna Navis, Allison R Webel, Catherine Jankowski, Vitor H F Oliveira, Vincent Khuu, Paul F Cook, Kristine M Erlandson

Abstract: We conducted an observational cross-sectional study to explore whether food insecurity or undernutrition was associated with frailty or low physical functioning in aging persons with HIV (PWH). Forty-eight PWH aged 50 years and older were enrolled. Independent samples t -tests and chi-square tests were used to examine the relationship of food insecurity or undernutrition to frailty or physical function. Participants were 58.6 (±6.3) years old, 83% male, 77% White, 21% Hispanic. In total, 44% experienced food insecurity and 71% experienced undernutrition, whereas 23% were frail and 69% were prefrail. Food insecurity was associated with impaired total short physical performance battery score ( p = .02), impaired balance ( p = .02), slower chair rise time ( p = .03), and weight loss within 12 months ( p = .05). Undernutrition was related to female gender ( p = .01), worse frailty ( p = .04), and weaker grip strength ( p = .03). In this sample of undernourished and frail PWH, strong relationships between undernutrition and frailty were observed.

摘要:我们进行了一项观察性横断面研究,以探讨食物不安全或营养不良是否与老年艾滋病病毒感染者(PWH)的虚弱或身体机能低下有关。研究共招募了 48 名 50 岁及以上的艾滋病感染者。采用独立样本 t 检验和卡方检验来研究食物不安全或营养不良与虚弱或身体功能的关系。参与者的年龄为 58.6 (±6.3) 岁,83% 为男性,77% 为白人,21% 为西班牙裔。总计有 44% 的人经历过食物不安全,71% 的人经历过营养不良,而 23% 的人体弱,69% 的人体弱前期。食物不安全与短期体能表现电池总分受损(p = .02)、平衡能力受损(p = .02)、起坐时间变慢(p = .03)和 12 个月内体重下降(p = .05)有关。营养不良与女性性别(p = .01)、虚弱程度(p = .04)和握力(p = .03)有关。在这一营养不良和虚弱的残疾人样本中,可以观察到营养不良与虚弱之间的密切关系。
{"title":"Impact of Food Insecurity and Undernutrition on Frailty and Physical Functioning in Aging People With HIV in the United States.","authors":"Christine Horvat Davey, Brianna Navis, Allison R Webel, Catherine Jankowski, Vitor H F Oliveira, Vincent Khuu, Paul F Cook, Kristine M Erlandson","doi":"10.1097/JNC.0000000000000395","DOIUrl":"10.1097/JNC.0000000000000395","url":null,"abstract":"<p><strong>Abstract: </strong>We conducted an observational cross-sectional study to explore whether food insecurity or undernutrition was associated with frailty or low physical functioning in aging persons with HIV (PWH). Forty-eight PWH aged 50 years and older were enrolled. Independent samples t -tests and chi-square tests were used to examine the relationship of food insecurity or undernutrition to frailty or physical function. Participants were 58.6 (±6.3) years old, 83% male, 77% White, 21% Hispanic. In total, 44% experienced food insecurity and 71% experienced undernutrition, whereas 23% were frail and 69% were prefrail. Food insecurity was associated with impaired total short physical performance battery score ( p = .02), impaired balance ( p = .02), slower chair rise time ( p = .03), and weight loss within 12 months ( p = .05). Undernutrition was related to female gender ( p = .01), worse frailty ( p = .04), and weaker grip strength ( p = .03). In this sample of undernourished and frail PWH, strong relationships between undernutrition and frailty were observed.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 3","pages":"238-247"},"PeriodicalIF":2.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10392447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the All of Us Database: An Invitation to Nurse Scientists and Public Health Researchers. 探索我们所有的数据库:对护士科学家和公共卫生研究人员的邀请。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-05-01 DOI: 10.1097/JNC.0000000000000405
Carole Treston
{"title":"Exploring the All of Us Database: An Invitation to Nurse Scientists and Public Health Researchers.","authors":"Carole Treston","doi":"10.1097/JNC.0000000000000405","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000405","url":null,"abstract":"","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 3","pages":"325-326"},"PeriodicalIF":2.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9573542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Factors Are Associated With Willingness to Use HIV Pre-exposure Prophylaxis (PrEP) Among U.S. Men Who Have Sex With Men Not on PrEP? A Systematic Review and Meta-analysis. 哪些因素与美国男性发生性行为时使用HIV暴露前预防(PrEP)的意愿相关?系统回顾和荟萃分析。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 DOI: 10.1097/JNC.0000000000000384
Emiko Kamitani, Megan E Wichser, Yuko Mizuno, Julia B DeLuca, Darrel H Higa

Abstract: Pre-exposure prophylaxis (PrEP), an antiretroviral medication to prevent HIV, is becoming more widely available in the United States since the Federal Drug Administration approved it in 2012. However, PrEP use among men who have sex with men (MSM) is still limited and many MSM who are willing to take PrEP are not on PrEP. We performed a systematic review to identify factors associated with willingness to use PrEP among MSM who are not on PrEP. The majority of the 23 relevant studies had low risk of bias and used a cross-sectional design. Willingness was associated with being Hispanic/Latino (odds ratio [OR] = 1.68, 95% confidence interval [CI] [1.01-2.78]), Black (OR = 1.41, 95% CI [1.02-1.95]), younger (OR = 1.08, 95% CI [1.02-1.15]), having no college degree (OR = 1.37, 95% CI [1.12-1.59]), or low income (OR = 1.21, 95% CI [1.12-1.32]). A higher proportion of MSM who had recent condomless anal sex (OR = 1.85, 95% CI [1.49-2.29]) were diagnosed with sexually transmitted infection (OR = 1.60, 95% CI [1.27-2.01]), or MSM who had multiple sex partners (OR = 1.58, 95% CI [1.07-2.32]) were more willing to use PrEP compared with their respective counterparts. Findings suggest that MSM with racial/ethnic minority status, low-socioeconomic status, younger age, and engagement in HIV risk behaviors are willing to take PrEP but may lack access. Study limitations include the inability to conduct meta-analyses on certain predictor variables due to a small number of studies. This review identified MSM subpopulations who may benefit from interventions increasing PrEP access.

摘要:暴露前预防(PrEP)是一种用于预防HIV的抗逆转录病毒药物,自2012年获得美国联邦药物管理局批准以来,PrEP在美国的应用越来越广泛。然而,男男性行为者(MSM)使用PrEP的情况仍然有限,许多愿意服用PrEP的男男性行为者并未服用PrEP。我们进行了一项系统综述,以确定与未服用PrEP的男男性行为者使用PrEP意愿相关的因素。23项相关研究中的大多数具有低偏倚风险,并采用了横断设计。意愿与西班牙裔/拉丁裔(比值比[OR] = 1.68, 95%可信区间[CI][1.01-2.78])、黑人(OR = 1.41, 95% CI[1.02-1.95])、年轻(OR = 1.08, 95% CI[1.02-1.15])、没有大学学历(OR = 1.37, 95% CI[1.12-1.59])或低收入(OR = 1.21, 95% CI[1.12-1.32])相关。近期无安全套肛交的MSM (OR = 1.85, 95% CI[1.49-2.29])被诊断为性传播感染的比例较高(OR = 1.60, 95% CI[1.27-2.01]),或有多个性伴侣的MSM (OR = 1.58, 95% CI[1.07-2.32])更愿意使用PrEP。研究结果表明,少数民族、低社会经济地位、年龄较小、有艾滋病毒风险行为的男男性行为者愿意接受PrEP,但可能缺乏获取途径。研究的局限性包括由于研究数量较少,无法对某些预测变量进行荟萃分析。本综述确定了可能从增加PrEP获取的干预措施中受益的MSM亚人群。
{"title":"What Factors Are Associated With Willingness to Use HIV Pre-exposure Prophylaxis (PrEP) Among U.S. Men Who Have Sex With Men Not on PrEP? A Systematic Review and Meta-analysis.","authors":"Emiko Kamitani,&nbsp;Megan E Wichser,&nbsp;Yuko Mizuno,&nbsp;Julia B DeLuca,&nbsp;Darrel H Higa","doi":"10.1097/JNC.0000000000000384","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000384","url":null,"abstract":"<p><strong>Abstract: </strong>Pre-exposure prophylaxis (PrEP), an antiretroviral medication to prevent HIV, is becoming more widely available in the United States since the Federal Drug Administration approved it in 2012. However, PrEP use among men who have sex with men (MSM) is still limited and many MSM who are willing to take PrEP are not on PrEP. We performed a systematic review to identify factors associated with willingness to use PrEP among MSM who are not on PrEP. The majority of the 23 relevant studies had low risk of bias and used a cross-sectional design. Willingness was associated with being Hispanic/Latino (odds ratio [OR] = 1.68, 95% confidence interval [CI] [1.01-2.78]), Black (OR = 1.41, 95% CI [1.02-1.95]), younger (OR = 1.08, 95% CI [1.02-1.15]), having no college degree (OR = 1.37, 95% CI [1.12-1.59]), or low income (OR = 1.21, 95% CI [1.12-1.32]). A higher proportion of MSM who had recent condomless anal sex (OR = 1.85, 95% CI [1.49-2.29]) were diagnosed with sexually transmitted infection (OR = 1.60, 95% CI [1.27-2.01]), or MSM who had multiple sex partners (OR = 1.58, 95% CI [1.07-2.32]) were more willing to use PrEP compared with their respective counterparts. Findings suggest that MSM with racial/ethnic minority status, low-socioeconomic status, younger age, and engagement in HIV risk behaviors are willing to take PrEP but may lack access. Study limitations include the inability to conduct meta-analyses on certain predictor variables due to a small number of studies. This review identified MSM subpopulations who may benefit from interventions increasing PrEP access.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"135-145"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184317/pdf/nihms-1892318.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10016481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Injectable Long-Acting Cabotegravir-Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start. 针对艾滋病毒/艾滋病感染者的注射用长效 Cabotegravir-Rilpivirine 疗法:从一开始就解决实施障碍。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 Epub Date: 2023-01-20 DOI: 10.1097/JNC.0000000000000386
Rogério M Pinto, Evan Hall, Ryan Tomlin

Abstract: Injectable cabotegravir and rilpivirine (CAB/RPV), administered bimonthly by a medical provider, is convenient and improves privacy and medication management. One year after approval, myriad implementation barriers threaten the access and sustainability of this life-saving innovation: (1) eligibility issues (viral suppression, drug resistance, and failed oral regimens); (2) injection requires medical provider and transportation to facility; (3) strict medication adherence; (4) life challenges-mental health, homelessness, joblessness; and (5) lack of insurance and high cost. Universal implementation of CAB/RPV calls for social, human, and health organizations to partner and provide HIV continuum of care and prevention services to facilitate CAB/RPV access and maintenance and for transparent health insurance billing practices to abate uncertainty concerning CAB/RPV's classification as a pharmaceutical or medical benefit and related cost implications.

摘要:注射用卡博替拉韦和利匹韦林(CAB/RPV)由医疗服务提供者每两个月给药一次,不仅方便,而且改善了隐私和用药管理。在获得批准一年后,无数的实施障碍威胁着这一拯救生命的创新技术的可及性和可持续性:(1)资格问题(病毒抑制、耐药性和口服治疗失败);(2)注射需要医疗服务提供者和交通设施;(3)严格的用药依从性;(4)生活挑战--精神健康、无家可归、失业;以及(5)缺乏保险和高昂的费用。普及 CAB/RPV 要求社会、人文和卫生组织结成伙伴关系,提供艾滋病毒持续护理和预防服务,以促进 CAB/RPV 的获取和维持,并要求透明的医疗保险计费做法,以减少 CAB/RPV 被归类为药品或医疗福利以及相关费用影响方面的不确定性。
{"title":"Injectable Long-Acting Cabotegravir-Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start.","authors":"Rogério M Pinto, Evan Hall, Ryan Tomlin","doi":"10.1097/JNC.0000000000000386","DOIUrl":"10.1097/JNC.0000000000000386","url":null,"abstract":"<p><strong>Abstract: </strong>Injectable cabotegravir and rilpivirine (CAB/RPV), administered bimonthly by a medical provider, is convenient and improves privacy and medication management. One year after approval, myriad implementation barriers threaten the access and sustainability of this life-saving innovation: (1) eligibility issues (viral suppression, drug resistance, and failed oral regimens); (2) injection requires medical provider and transportation to facility; (3) strict medication adherence; (4) life challenges-mental health, homelessness, joblessness; and (5) lack of insurance and high cost. Universal implementation of CAB/RPV calls for social, human, and health organizations to partner and provide HIV continuum of care and prevention services to facilitate CAB/RPV access and maintenance and for transparent health insurance billing practices to abate uncertainty concerning CAB/RPV's classification as a pharmaceutical or medical benefit and related cost implications.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"216-220"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/e0/jnc-34-216.PMC9951790.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiometabolic Diseases and Quality-of-Life Outcomes in Adults With HIV in the Deep South: A Cross-sectional Study. 深南地区艾滋病毒感染者的心脏代谢疾病和生活质量结果:一项横断面研究。
IF 1.6 4区 医学 Q2 NURSING Pub Date : 2023-03-01 Epub Date: 2022-12-26 DOI: 10.1097/JNC.0000000000000387
Ene M Enogela, Raymond Jones, Thomas W Buford, David E Vance, Pariya L Fazeli

Abstract: The role of cardiometabolic diseases (CMDs) on physical health-related quality of life (P-HRQoL) and quality of sleep was examined among 261 PLWH ≥40 years, recruited from a university-affiliated HIV clinic in the Deep U.S. South. Using a cross-sectional study design, participants completed the Medical Outcomes Study HIV Health Survey (MOS-HIV; P-HRQoL) and Pittsburgh Sleep Quality Index. The overall prevalence of self-reporting ≥1 CMD was 64.4%. P-HRQoL scores were lower in PLWH with ≥1 CMD compared with those with no CMDs (45.53 ± 11.54 vs. 49.67 ± 10.77, p <.01). Poor sleep quality was higher among participants with ≥1 CMD compared with those with no CMDs (9.28 ± 4.42 vs. 7.26 ± 4.17, p <.01). Each additional CMD resulted in a 1.83-point decrease in P-HRQoL and 0.74-point increase in poor sleep quality scores. Interventions that focus on targeting these quality-of-life domains in PLWH with CMDs are needed.

摘要:研究人员从美国南部偏远地区一所大学下属的艾滋病诊所招募了 261 名年龄≥40 岁的艾滋病毒感染者,研究了心脏代谢疾病(CMDs)对身体健康相关生活质量(P-HRQoL)和睡眠质量的影响。采用横断面研究设计,参与者完成了医疗结果研究艾滋病健康调查(MOS-HIV;P-HRQoL)和匹兹堡睡眠质量指数。自我报告≥1次CMD的总患病率为64.4%。与没有 CMD 的 PLWH 相比,≥1 CMD 的 PLWH 的 P-HRQoL 分数较低(45.53 ± 11.54 vs. 49.67 ± 10.77,p
{"title":"Cardiometabolic Diseases and Quality-of-Life Outcomes in Adults With HIV in the Deep South: A Cross-sectional Study.","authors":"Ene M Enogela, Raymond Jones, Thomas W Buford, David E Vance, Pariya L Fazeli","doi":"10.1097/JNC.0000000000000387","DOIUrl":"10.1097/JNC.0000000000000387","url":null,"abstract":"<p><strong>Abstract: </strong>The role of cardiometabolic diseases (CMDs) on physical health-related quality of life (P-HRQoL) and quality of sleep was examined among 261 PLWH ≥40 years, recruited from a university-affiliated HIV clinic in the Deep U.S. South. Using a cross-sectional study design, participants completed the Medical Outcomes Study HIV Health Survey (MOS-HIV; P-HRQoL) and Pittsburgh Sleep Quality Index. The overall prevalence of self-reporting ≥1 CMD was 64.4%. P-HRQoL scores were lower in PLWH with ≥1 CMD compared with those with no CMDs (45.53 ± 11.54 vs. 49.67 ± 10.77, p <.01). Poor sleep quality was higher among participants with ≥1 CMD compared with those with no CMDs (9.28 ± 4.42 vs. 7.26 ± 4.17, p <.01). Each additional CMD resulted in a 1.83-point decrease in P-HRQoL and 0.74-point increase in poor sleep quality scores. Interventions that focus on targeting these quality-of-life domains in PLWH with CMDs are needed.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"171-181"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10391965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV Continuum of Care Among People Who Inject Drugs in Iran: A Cross-sectional Study. 伊朗注射毒品者的艾滋病毒连续护理:一项横断面研究。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 DOI: 10.1097/JNC.0000000000000391
Nima Ghalekhani, Ali Mirzazadeh, Fatemeh Tavakoli, Ghazal Mousavian, Mehrdad Khezri, Omid Zamani, Soheil Mehmandoost, Ali Akbar Haghdoost, Hamid Sharifi

Abstract: People living with HIV who inject drugs may have lower access to treatment services. We aimed to assess the HIV continuum of care among people who inject drugs (PWID) in Iran. Data were collected from 2,663 PWID who were recruited via respondent-driven sampling from 11 cities of Iran between June 2019 and March 2020. Participants who tested positive for HIV infection were asked questions to calculate the status of HIV cascade of care. Of 95 PWID living with HIV, 67% were aware of their HIV status, 57% were linked to care service and initiated ART, 49% retained on ART, and only 15% had viral load less than 1,000 copies/ml. About half of the PWID diagnosed with HIV ever started ART and less than one in six were virally suppressed. Strategies to improve linkage to ART programs and ART retention may improve HIV care outcomes among PWID in Iran.

摘要:注射毒品的艾滋病毒感染者获得治疗服务的机会可能较低。我们的目的是评估伊朗注射吸毒者(PWID)的艾滋病毒连续护理。数据收集自2019年6月至2020年3月期间通过受访者驱动的抽样从伊朗11个城市招募的2663名PWID。艾滋病毒感染检测呈阳性的参与者被问及计算艾滋病毒级联护理状态的问题。在95名感染艾滋病毒的PWID中,67%知道自己的艾滋病毒状况,57%与护理服务相关并开始抗逆转录病毒治疗,49%继续接受抗逆转录病毒治疗,只有15%的病毒载量低于1000拷贝/毫升。大约一半被诊断患有艾滋病毒的PWID患者开始接受抗逆转录病毒治疗,不到六分之一的人病毒受到抑制。改善与抗逆转录病毒治疗方案的联系和抗逆转录病毒治疗保留的战略可能会改善伊朗艾滋病毒感染者的艾滋病毒护理结果。
{"title":"HIV Continuum of Care Among People Who Inject Drugs in Iran: A Cross-sectional Study.","authors":"Nima Ghalekhani,&nbsp;Ali Mirzazadeh,&nbsp;Fatemeh Tavakoli,&nbsp;Ghazal Mousavian,&nbsp;Mehrdad Khezri,&nbsp;Omid Zamani,&nbsp;Soheil Mehmandoost,&nbsp;Ali Akbar Haghdoost,&nbsp;Hamid Sharifi","doi":"10.1097/JNC.0000000000000391","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000391","url":null,"abstract":"<p><strong>Abstract: </strong>People living with HIV who inject drugs may have lower access to treatment services. We aimed to assess the HIV continuum of care among people who inject drugs (PWID) in Iran. Data were collected from 2,663 PWID who were recruited via respondent-driven sampling from 11 cities of Iran between June 2019 and March 2020. Participants who tested positive for HIV infection were asked questions to calculate the status of HIV cascade of care. Of 95 PWID living with HIV, 67% were aware of their HIV status, 57% were linked to care service and initiated ART, 49% retained on ART, and only 15% had viral load less than 1,000 copies/ml. About half of the PWID diagnosed with HIV ever started ART and less than one in six were virally suppressed. Strategies to improve linkage to ART programs and ART retention may improve HIV care outcomes among PWID in Iran.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"182-187"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
ANAC Policy Agenda 2022-2025. 《亚太共同体政策议程2022-2025》。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 DOI: 10.1097/JNC.0000000000000393
Carole Treston
{"title":"ANAC Policy Agenda 2022-2025.","authors":"Carole Treston","doi":"10.1097/JNC.0000000000000393","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000393","url":null,"abstract":"","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"221-222"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10392446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Study Examining a Culture-centric Story to Promote HIV Testing in African American Women in the South. 一项以文化为中心的试点研究,以促进南部非洲裔美国妇女的艾滋病毒检测。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 DOI: 10.1097/JNC.0000000000000390
Alyssa G Robillard, Jamie Troutman, Chelsea Perry, Linda Larkey
Like many health conditions that disproportionately affect Blackwomen,HIV is one that highlights health inequalities for Black women that persist despite overall improvements in women’s health (Chinn et al., 2021). Despite advances in treatment and prevention, Black women remain disproportionately overrepresented in HIV incidence amongwomen, comprising 54%of newly diagnosed cases in 2020 (CDC, 2022). The prevalence of HIV is highest in the South (CDC, 2022), yetHIV stigma, racial discrimination, poverty, limited access to quality care, and gender inequity perpetuate inequalities and negatively affect HIV prevention, care, and treatment. These social andstructural inequitieshavebeenhampered further by inconsistent efforts to prioritize Black women in the HIV response over the course of the epidemic despite consistent disparities (Bond et al., 2021; Holliday, et al., in press). The disproportionate rates of new infection, and the bold plan of ending the HIV epidemic (Department of Health and Human Services, 2022), warrant continued efforts around “treatment as prevention” as well as efforts targeting the very first stage of the HIV care continuum: diagnosis through increased testing. Populationlevel increases in testing mask less than ideal testing patterns in groups at increased risk for contracting HIV, including Black women (Hall et al., 2015; Kapadia & Landers, 2020). In a nationally representative sample, 67.8% of heterosexual Black women reported “ever” having been tested (Agenor et al., 2019). However, lifetime testingdoesnot account for testing in thepast year or testing among those at “recent” risk. A study examining themedian interval since last testing for peoplewith recent risk found 1,047 and 534 days for women and Black respondents, respectively (Pitasi et al., 2018), offering evidenceof delayed testing that has implications for delayed diagnosis and treatment. An analysis of CDC’s National Health Interview Survey reported that only 21%of Blackwomenwere tested in 2017 comparedwith 6% of White women (Kaiser Family Foundation, 2020). The National Survey on HIV in the Black Community (NSHBC) found annual testing to be 40%amongwomen (Ojikutu et al., 2020), and the COVID-19 pandemic has led to further declines in testing (CDC, 2022). The NSHBC found that higher perceived risk was associated with higher testing. However, a study of younger Black women aged 18–29 years found that neither high-risk sex nor “high-risk”male partners were associated with HIV testing (Jones et al., 2020). Although Black women may be more likely to be tested compared with other groups, these findings are indicative of testing inconsistencies and gaps in prevention and perceived risk. The “test and treat” strategy has implications for diagnosis and linkage to care, as well as prevention among people at increased risk for contracting HIV. Increased, focused testing can serve as a gateway to pre-exposure prophylaxis (PrEP), a proven biomedical strategy to prevent HIV
{"title":"A Pilot Study Examining a Culture-centric Story to Promote HIV Testing in African American Women in the South.","authors":"Alyssa G Robillard,&nbsp;Jamie Troutman,&nbsp;Chelsea Perry,&nbsp;Linda Larkey","doi":"10.1097/JNC.0000000000000390","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000390","url":null,"abstract":"Like many health conditions that disproportionately affect Blackwomen,HIV is one that highlights health inequalities for Black women that persist despite overall improvements in women’s health (Chinn et al., 2021). Despite advances in treatment and prevention, Black women remain disproportionately overrepresented in HIV incidence amongwomen, comprising 54%of newly diagnosed cases in 2020 (CDC, 2022). The prevalence of HIV is highest in the South (CDC, 2022), yetHIV stigma, racial discrimination, poverty, limited access to quality care, and gender inequity perpetuate inequalities and negatively affect HIV prevention, care, and treatment. These social andstructural inequitieshavebeenhampered further by inconsistent efforts to prioritize Black women in the HIV response over the course of the epidemic despite consistent disparities (Bond et al., 2021; Holliday, et al., in press). The disproportionate rates of new infection, and the bold plan of ending the HIV epidemic (Department of Health and Human Services, 2022), warrant continued efforts around “treatment as prevention” as well as efforts targeting the very first stage of the HIV care continuum: diagnosis through increased testing. Populationlevel increases in testing mask less than ideal testing patterns in groups at increased risk for contracting HIV, including Black women (Hall et al., 2015; Kapadia & Landers, 2020). In a nationally representative sample, 67.8% of heterosexual Black women reported “ever” having been tested (Agenor et al., 2019). However, lifetime testingdoesnot account for testing in thepast year or testing among those at “recent” risk. A study examining themedian interval since last testing for peoplewith recent risk found 1,047 and 534 days for women and Black respondents, respectively (Pitasi et al., 2018), offering evidenceof delayed testing that has implications for delayed diagnosis and treatment. An analysis of CDC’s National Health Interview Survey reported that only 21%of Blackwomenwere tested in 2017 comparedwith 6% of White women (Kaiser Family Foundation, 2020). The National Survey on HIV in the Black Community (NSHBC) found annual testing to be 40%amongwomen (Ojikutu et al., 2020), and the COVID-19 pandemic has led to further declines in testing (CDC, 2022). The NSHBC found that higher perceived risk was associated with higher testing. However, a study of younger Black women aged 18–29 years found that neither high-risk sex nor “high-risk”male partners were associated with HIV testing (Jones et al., 2020). Although Black women may be more likely to be tested compared with other groups, these findings are indicative of testing inconsistencies and gaps in prevention and perceived risk. The “test and treat” strategy has implications for diagnosis and linkage to care, as well as prevention among people at increased risk for contracting HIV. Increased, focused testing can serve as a gateway to pre-exposure prophylaxis (PrEP), a proven biomedical strategy to prevent HIV","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"207-215"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of Mothers Living With HIV in a South African Prevention of Mother-to-Child Transmission of HIV Programme: A Qualitative Descriptive Study. 南非预防艾滋病毒母婴传播方案中感染艾滋病毒母亲的经验:一项定性描述性研究。
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 DOI: 10.1097/JNC.0000000000000372
Linda Velapi, Pat M Mayers, Jose Frantz

Abstract: More than 90% of all HIV infections in children result from mother to child transmission. Elimination of mother-child transmission is a global priority and vital for the improvement of child survival in high-burden, limited resource settings. Retention in HIV care is vital to reduce transmission risk. This qualitative study explored the experiences and adherence challenges of mothers living with HIV of the Prevention of Mother-to-Child Transmission of HIV (PMTCT) programme in Khayelitsha, Cape Town, South Africa. Interviews were conducted with purposively selected participants enrolled in a PMTCT programme at a primary care facility. Thematic analysis generated six themes. Findings demonstrate the complexity of living as a woman with HIV in a socioeconomically disadvantaged and marginalized periurban community. For each woman, there is a set of concerns relating to person, home, community, and clinic which may affect her understanding, acceptance of, and adherence to the PMTCT programme.

摘要:90%以上的儿童艾滋病毒感染是由母婴传播引起的。消除母婴传播是一项全球优先事项,对于在高负担、资源有限的环境中改善儿童生存至关重要。坚持艾滋病毒护理对降低传播风险至关重要。这项定性研究探讨了南非开普敦Khayelitsha的预防母婴艾滋病毒传播(PMTCT)项目中感染艾滋病毒的母亲的经历和坚持挑战。对在初级保健机构参加预防母婴传播方案的有目的选择的参与者进行了访谈。专题分析产生了六个主题。研究结果表明,作为一名感染艾滋病毒的妇女,在社会经济上处于不利地位和边缘化的城市周边社区生活的复杂性。对于每个妇女来说,都有一系列与个人、家庭、社区和诊所有关的问题,这些问题可能会影响她对预防母婴传播方案的理解、接受和遵守。
{"title":"Experiences of Mothers Living With HIV in a South African Prevention of Mother-to-Child Transmission of HIV Programme: A Qualitative Descriptive Study.","authors":"Linda Velapi,&nbsp;Pat M Mayers,&nbsp;Jose Frantz","doi":"10.1097/JNC.0000000000000372","DOIUrl":"https://doi.org/10.1097/JNC.0000000000000372","url":null,"abstract":"<p><strong>Abstract: </strong>More than 90% of all HIV infections in children result from mother to child transmission. Elimination of mother-child transmission is a global priority and vital for the improvement of child survival in high-burden, limited resource settings. Retention in HIV care is vital to reduce transmission risk. This qualitative study explored the experiences and adherence challenges of mothers living with HIV of the Prevention of Mother-to-Child Transmission of HIV (PMTCT) programme in Khayelitsha, Cape Town, South Africa. Interviews were conducted with purposively selected participants enrolled in a PMTCT programme at a primary care facility. Thematic analysis generated six themes. Findings demonstrate the complexity of living as a woman with HIV in a socioeconomically disadvantaged and marginalized periurban community. For each woman, there is a set of concerns relating to person, home, community, and clinic which may affect her understanding, acceptance of, and adherence to the PMTCT programme.</p>","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"188-197"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10007599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open Access Publishing and Global HIV Nursing-An Issue of Access and Equity! 开放获取出版与全球艾滋病护理--获取与公平问题!
IF 2 4区 医学 Q2 NURSING Pub Date : 2023-03-01 Epub Date: 2023-02-07 DOI: 10.1097/JNC.0000000000000396
Michael V Relf
{"title":"Open Access Publishing and Global HIV Nursing-An Issue of Access and Equity!","authors":"Michael V Relf","doi":"10.1097/JNC.0000000000000396","DOIUrl":"10.1097/JNC.0000000000000396","url":null,"abstract":"","PeriodicalId":50263,"journal":{"name":"Janac-Journal of the Association of Nurses in Aids Care","volume":"34 2","pages":"133-134"},"PeriodicalIF":2.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10016513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Janac-Journal of the Association of Nurses in Aids Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1